Advertisement

Ads Placeholder
Loading...

Enochian Biosciences, Inc.

ENOBNASDAQ
Healthcare
Biotechnology
$0.71
$0.01(1.79%)
U.S. Market opens in 21h 57m

Enochian Biosciences, Inc. (ENOB) Stock Overview

Explore Enochian Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap45.4M
P/E Ratio-0.13
EPS (TTM)$-2.07
ROE-12.41%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ENOB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Enochian Biosciences, Inc. (ENOB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.13 and a market capitalization of 45.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-70.44%
1-Month Change
1.79%
3-Month Change
-13.11%
6-Month Change
-38.04%
Year-to-Date (YTD) Change
-36.38%
1-Year Change
-66.86%
3-Year Change
-81.78%
5-Year Change
-85.49%
All-Time (Max) Change
-88.13%

Contact Information

305 918 1980
Century City Medical Plaza, Los Angeles, CA, 90067-2012

Company Facts

220 Employees
IPO DateFeb 7, 2018
CountryUS

Frequently Asked Questions